Floatz logo

23 assets in Grade III Glioma

Therapeutic assets addressing Grade III Glioma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Everolimus
Grade III Glioma
Nationwide Children's HospitalP2B (63)
Pamiparib
Grade III Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsP1/2B (57)
Dabrafenib
Grade III Glioma
National Cancer Institute (NCI)P2CCC (53)
g207
Grade III Glioma
Pediatric Brain Tumor ConsortiumP2CCC (53)
Olaparib
Grade III Glioma
National Cancer Institute (NCI)P2CCC (53)
Olutasidenib
Grade III Glioma
Rigel PharmaceuticalsP2CCC (53)
Ribociclib
Grade III Glioma
Nationwide Children's HospitalP2CCC (53)
Trametinib
Grade III Glioma
National Cancer Institute (NCI)P2CCC (53)
Arm 1: Il13Ra2-Specific Car Tcm Cells
Grade III Glioma
City of Hope Medical CenterP1CC (43)
Arm 2: Il13Ra2-Specific Car Tcm Cells
Grade III Glioma
City of Hope Medical CenterP1CC (43)
Arm 3: Il13Ra2-Specific Car Tcm Cells
Grade III Glioma
City of Hope Medical CenterP1CC (43)
Arm 4: Il13Ra2-Specific Car Tcm Cells
Grade III Glioma
City of Hope Medical CenterP1CC (43)
Carboxylesterase-Expressing Allogeneic Neural Stem Cells
Grade III Glioma
City of Hope Medical CenterP1CC (43)
CD19t
Grade III Glioma
City of Hope Medical CenterP1CC (43)
Chlorotoxin -Cd28-Cd3Zeta-Cd19T-Expressing Car T-Lymphocytes
Grade III Glioma
City of Hope Medical CenterP1CC (43)
her2bbζ/cd19t+ t cells
Grade III Glioma
City of Hope Medical CenterP1CC (43)
HER2(EQ)BBzeta
Grade III Glioma
City of Hope Medical CenterP1CC (43)
Irinotecan
Grade III Glioma
City of Hope Medical CenterP1CC (43)
Nivolumab
Grade III Glioma
Sabine Mueller, MD, PhDP1CC (43)
Onc 206
Grade III Glioma
Sabine Mueller, MD, PhDP1CC (43)
Lorlatinib
Grade III Glioma
Nationwide Children's HospitalEarly P1C (39)
Ketoconazole
Grade III Glioma
Universitas PadjadjaranEarly P1NR ()
Triapine
Grade III Glioma
Northwestern UniversityP1NR ()